A new, powerful Citizen Portal experience is ready. Switch now

Oversight committee opens path to OPEGA probe of sole‑source procurement and seeks DHHS briefings on MaineCare allegations

January 24, 2026 | 2026 Legislature ME, Maine


This article was created by AI summarizing key points discussed. AI makes mistakes, so for full details and context, please refer to the video of the full meeting. Please report any errors so we can fix them. Report an error »

Oversight committee opens path to OPEGA probe of sole‑source procurement and seeks DHHS briefings on MaineCare allegations
A letter from Senators Timberlake, Farrin, and Garen asking OPEGA to investigate MaineCare program integrity and disbursements prompted extensive debate about scope, duplication with criminal investigations, and next steps. Senator Farrin told the committee recent media reports and agency actions — including suspension of payments to Gateway Community Services — warranted a broad look at whether fraud has affected multiple programs and procurement practices.

Members repeatedly emphasized caution about conflating allegations with proven wrongdoing. Chair Craig Hickman reminded the committee to use the word "alleged" when discussing matters under investigation. Several members pointed to prior auditor findings: in FY 2024 the auditor reported more than $2,100,000,000 in contracts reviewed and identified 31 sole‑source procurement actions, 16 of which lacked documentation showing a reasonable investigation of alternatives.

Discussion centered on three discrete buckets in the letter: (1) alleged interpreter‑services fraud related to the Bureau of Motor Vehicles, (2) procurement practices and the 16 sole‑source cases flagged by the auditor, and (3) alleged MaineCare program fraud and the frequency and effectiveness of DHHS program‑integrity audits. Committee members split between urging immediate OPEGA action and recommending additional fact‑gathering from agency officials first. Several members with investigative or law‑enforcement backgrounds urged a proactive OPEGA review; others counseled waiting for the Department of Health and Human Services' fraud unit and for the Secretary of State to return with answers to previously posed questions.

The chair put a motion before the committee to direct OPEGA to begin an evaluation of sole‑source noncompetitive procurements with an initial focus on the 16 instances identified by the state auditor and to invite Department of Administrative and Financial Services officials to answer procurement questions at a future meeting. Senators Farrin and Stover moved and seconded the motion. The committee proceeded with that directive and asked OPEGA to come back with a formal scope of work for committee approval; the chair also asked OPEGA to compile recent published reports and audit summaries into the committee packet to align members on what is reported versus what has been established.

On the MaineCare allegations, members agreed at minimum to invite DHHS’s fraud/investigation unit to the next meeting to explain their processes and to ask OPEGA to assemble a digest of recent reporting and audit materials so members could better determine whether to direct a formal OPEGA investigation. Director Peter Slek said OPEGA would prepare a concise compilation of news items and relevant audit summaries to help the committee frame a scope of work and recommended sending specific written questions to invited agencies before their appearances.

The committee set invitations for Secretary of State representatives to appear on Feb. 13 and said it would consider a vote on additional OPEGA work once officials have briefed the committee and OPEGA presents a proposed scope.

View the Full Meeting & All Its Details

This article offers just a summary. Unlock complete video, transcripts, and insights as a Founder Member.

Watch full, unedited meeting videos
Search every word spoken in unlimited transcripts
AI summaries & real-time alerts (all government levels)
Permanent access to expanding government content
Access Full Meeting

30-day money-back guarantee